Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs.
- 1 August 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 78 (2) , 473-480
- https://doi.org/10.1161/01.cir.78.2.473
Abstract
It has been postulated that oxygen-centered free radicals are produced in significant quantities upon reperfusion of ischemic myocardium and could cause the death of myocytes that are still reversibly injured at the end of ischemia ("reperfusion injury"). However, we have shown previously that anti-free radical therapies including superoxide dismutase (SOD) and inhibitors of xanthine oxidase did not limit infarct size after 40 minutes of ischemia and 4 days of reperfusion in dogs. To test whether 40 minutes of ischemia is too brief a period to produce the prerequisite conditions for free radical-mediated necrosis upon reperfusion, we studied infarcts produced by 90 minutes of ischemia followed by reperfusion. Dogs in an SOD-catalase group received a 60-minute infusion of SOD (15,000 units/kg) and catalase (55,000 units/kg) beginning 25 minutes before and ending 35 minutes after reperfusion. A second group of dogs received a single injection of the xanthine oxidase inhibitor oxypurinol (20 mg/kg) 25 minutes before reperfusion. Infarct size was assessed histologically relative to the size of the area at risk and to collateral blood flow to the ischemic region. Infarct size as a percentage of the area at risk was similar in the control group (40.7 +/- 5.5%, n = 11), the SOD-catalase group (38.0 +/- 6.4%; n = 8), and the oxypurinol-treated group (41.4 +/- 6.1%; n = 7) [p = not significant (NS) by analysis of variance]. In controls, there was an inverse relation between infarct size and collateral blood flow; neither of the treatments altered this relation (p = NS by analysis of covariance).(ABSTRACT TRUNCATED AT 250 WORDS)This publication has 21 references indexed in Scilit:
- Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardiumPublished by Elsevier ,2002
- The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusionJournal of the American College of Cardiology, 1988
- Role of xanthine oxidase inhibitor as free radical scavenger: A novel mechanism of action of allopurinol and oxypurinol in myocardial salvageBiochemical and Biophysical Research Communications, 1987
- Identification of free radicals in myocardial ischemia/reperfusion by spin trapping with nitrone DMPOFEBS Letters, 1987
- Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury.Circulation, 1986
- Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion modelJournal of Molecular and Cellular Cardiology, 1986
- Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.Circulation, 1986
- Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarctsCardiovascular Research, 1985
- Animal models for protecting ischemic myocardium: results of the NHLBI Cooperative Study. Comparison of unconscious and conscious dog models.Circulation Research, 1985
- Xanthine oxidase as a source of free radical damage in myocardial ischemiaJournal of Molecular and Cellular Cardiology, 1985